ACAbha Cherkani-Hassani

Abha Cherkani-Hassani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abha Cherkani-Hassani has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Imane Ghanname

    Pharmacology, Mohammed V University in Rabat, Rabat, MAR

    7 shared publications
  • Nezha Mouane

    Department of Pediatrics, Hepatology, Gastroenterology, and Nutrition, University Children’s Hospital Ibn Sina, Rabat, MAR

    7 shared publications
  • Meriem Slaoui

    Laboratory of Histology, Embryology, and Cytogenetics, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Rabat, MAR

    3 shared publications
  • Abdelhakim Bouyahya

    Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco

    2 shared publications
  • Abdelilah Belhaj

    Laboratory of Quality Control of Waters, National Office of Electricity and Drinking Water (ONEE), Rabat, Morocco

    2 shared publications
  • Anass Doukkali

    Laboratory of Analytical Chemistry, Department of Drug Sciences, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat , Rabat , Morocco

    2 shared publications

Latest Publications

  • Open Access

    Dynamic Relationship Between High D-Dimer Levels and the In-Hospital Mortality Among COVID-19 Patients: A Moroccan Study

    by Bouchra Benfathallah, Abdellatif Boutagayout, Abha Cherkani Hassani, Hassan Ihazmade, Redouane Abouqal, Laila Benchekroun

    This study included 221 patients with COVID-19 who were admitted to the emergency department of Avicenne Hospital in Rabat between August 2020 and August 2021. Patients were divided into three groups according to their D-dimer levels (2 µg/mL). Adjusted and unadjusted logistic regression analyses were performed to assess the association between elevated D-dimer levels and in-hospital mortality. Pearson’s correlation analysis was performed to explore the relationship between D-dimer levels and various biological and clinical parameters. The results revealed a statistically significant difference in the mean (SD) age among the three groups (p = 0.006). Analysis showed a statistically significant difference in the means (SD) of oxygen saturation, duration of hospital stay, and breathing rate among the three independent groups of COVID-19 patients. Patients with elevated D-dimer levels (greater than 2 µg/mL) experienced worse outcomes than those in the other groups, with severity, transfer to intensive care, and in-hospital mortality of 55 (40.7%), 35 (16%), and 24 (11%) patients, respectively, with p-values of 0.048, 0.002, and 0.002, respectively. Patients in the D-dimer > 2 µg/mL group had significantly higher C-reactive protein (CRP), lactate dehydrogenase, urea, cardiac troponin, B-type natriuretic peptide, and ferritin levels than those in the other two groups. The p-value was significant among the three groups (p = 0.044, p = 0.001, and p < 0.001). Age and elevated D-dimer levels (greater than 2 µg/mL) were associated with mortality in patients diagnosed with COVID-19. Correlation analysis indicated that D-dimer in COVID-19 patients is associated with worsening respiratory, hepatic, cardiac, and coagulation parameters, suggesting their utility as an integrative marker of disease severity. D-dimer levels > 2 µg/mL were identified as an independent risk factor for COVID-19 in-hospital mortality. Measuring and monitoring D-dimer levels can assist clinicians in taking timely actions and predicting the prognosis of patients with COVID-19.


  • Open Access

    Prevalence of Mouse Mammary Tumor Virus-Like Virus in Breast Milk and Associated Factors of Exposure Among Healthy Nursing Women in Morocco

    by Abha Cherkani Hassani, Meriem Slaoui, Bouchra Benfathallah, Imane Ghanname, Rachid Razine, Mohammed Attaleb, Mohammed El Mzibri, Nezha Mouane

    Background: The mouse mammary tumor virus (MMTV) has been identified as potentially oncogenic, and its presence in milk was reported and discussed. However, with respect to breast cancer etiology, the transmission routes for these viruses are not known. In this context, the objective of this study is to assess the presence of MMTV-like virus in breast milk and to explore the associated factors of its presence among healthy lactating women in Morocco. Methods: In this prospective study, milk samples were collected from 44 lactating women recruited from the Souissi Maternity Hospital of Rabat in Morocco. MMTV-like DNA was identified by polymerase chain reaction amplification using specific primers targeting the env gene. Results: The prevalence of the MMTV-like virus was 45.5% (20/44). Statistical analysis revealed a significant association with the use of henna. It seems that it increases the risk of the presence of MMTV-like virus in breast milk. The hypothesis could be the possible contamination of henna sold in bulk in local markets by urine and feces of mice during storage. Conclusion: Nevertheless, these results need to be confirmed by multicenter studies to thoroughly investigate the impact of other factors and the potential contamination of henna with the virus through urine and feces of mice during storage.

  • Open Access

    A comprehensive review on ethnomedicinal uses, phytochemistry, toxicology, and pharmacological activities of Dittrichia viscosa (L.) Greuter

    by Rania Jerada, Abdeljalil Er-Rakibi, Abha Cherkani Hassani, Hanane Benzeid, Abdelmoula El Ouardi, Hicham Harhar, Bey Hing Goh, Yoon-Yen Yow, Hooi-Leng Ser, Abdelhakim Bouyahya, et al.


  • Open Access

    Toxicological Review of Anticancer Plants Used in Traditional Medicine in Morocco

    by Soufiane Drioua, Abha Cherkani-Hassani, Otman El-Guourrami, Mouna Ameggouz, Ahmed Zahidi, Abdelhakim Bouyahaya, Sayyed Ibrahim Shah, Yaser Mohammed Al-Worafi, Long Chiau Ming, Hanane Benzaied, et al.

    In Morocco, traditional medicine utilizes many toxic plants for cancer treatment, despite a lack of scientific evidence supporting their effectiveness. Further research may be able to explore and discover the potential therapeutic effects of these plants' bioactive molecules with antioxidant and anticancer properties. Based on our review, we have determined that the 13 plants under examination possess various pharmacological and biological activities due to their diverse phytochemical composition. Despite their toxicity, these plants have a history of traditional use in Morocco for treating multiple diseases. Further research, including preclinical and clinical trials, should be conducted to investigate the potential therapeutic benefits of these plants. Moroccan cuisine commonly incorporates gruels, herbal drinks, and spicy beverages, which possess significant health benefits, including chemo-preventive properties and natural inhibitors against certain infections. These properties may aid in reducing the incidence of cancer and potentially have therapeutic effects in various human pathologies when consumed in appropriate amounts and in combination with a healthy lifestyle.


  • Levels of mercury in Moroccan breast milk and the affecting factors: CONTAMILK study

    by Abha Cherkani-Hassani, Meriem Slaoui, Imane Ghanname, Brahim Mojemmi, Abdelilah Belhaj, Brahim Kers, Majda Flayou, Nezha Mouane


  • Lead concentrations in breast milk of Moroccan nursing mothers and associated factors of exposure: CONTAMILK STUDY

    by Abha Cherkani-Hassani, Meriem Slaoui, Imane Ghanname, Brahim Mojemmi, Rachid Eljaoudi, Abdelilah Belhaj, Brahim Kers, Majda Flayou, Nezha Mouane


  • Aflatoxin M1 prevalence in breast milk in Morocco: Associated factors and health risk assessment of newborns “CONTAMILK study”

    by Abha Cherkani-Hassani, Imane Ghanname, Abdellah Zinedine, Hassan Sefrioui, Zineb Qmichou, Nezha Mouane


  • Ochratoxin a in breast milk in Morocco: the affecting dietary habits of the lactating mothers and the degree of exposure of newborns “CONTAMILK study”

    by Abha Cherkani-Hassani, Imane Ghanname, Abdellah Zinedine, Hassan Sefrioui, Zineb Qmichou, Nezha Mouane

    The aim of the present study is to evaluate the level of contamination of breast milk (BM) by ochratoxin A, among Moroccan lactating mothers in the city of Rabat, and to identify the associated factors of exposure, also to estimate the degree of exposure of the breastfeed infant. The analysis of ochratoxin A (OTA) was accomplished by ELISA method on 82 colostrum samples. OTA was detectable (>0.08 ng/mL) in 55% of samples with a maximum concentration of 10.04 ng/mL, and the levels exceeded 0.5 ng /mL in 50 % of the samples. In addition, several factors and dietary habits affect significantly the level of OTA in the analyzed samples of breast milk including, the consumption of industrial dairy products, the frequency of consumption of canned foods, dried fruits and legumes, also the period of breast milk collection. Besides, OTA was higher than the tolerable daily intake for 49% newborns. However, these results need to be confirmed by multicenter studies to more broadly estimate the levels of exposition of Moroccan population to OTA. Furthermore, awareness campaigns are recommended to inform the public, especially pregnant women and lactating women about appropriate preventive measures to limit exposure to this mycotoxin.


  • Cadmium Contamination in Breast Milk of Moroccan Lactating Women and the Associated Factors: CONTAMILK Study

    by Abha Cherkani-Hassani, Meriem Slaoui, Imane Ghanname, Brahim Mojemmi, Abdelilah Belhaj, Brahim Kers, Majda Flayou, Nezha Mouane

    The objectives of this study were to assess levels of contamination of breast milk (BM) by cadmium (Cd) among lactating mothers from Rabat, Morocco, and to investigate its association with several maternal habits, parameters, and factors. In addition, to estimate the daily intake of the newborns. Cd concentrations were measured by inductively coupled plasma-mass spectrometry (ICP-MS) in 70 human milk samples collected between the 2nd and 5th day postpartum. Accuracy of the analysis was checked by various methods including the use of reference material. A structured questionnaire was filled during the collection of milk reporting data concerning anthropometric, sociodemographic parameters, dietary and cosmetic habits, etc. The median (range) of Cd in human milk was 0.49 μg/L (range 0.013–95.19 μg/L) respectively. In 21 (30%) of 70 samples, Cd levels were higher than the normal reported by the World Health Organization (WHO) in BM (< 1 μg/L). Indeed, several factors affect significantly Cd levels in BM of the mothers such as low maternal education level, preterm delivery, cesarean delivery, and area of residence. Also, the frequency of consumption of milk and dairy products as well dried fruits and wheat bread and the frequency of use of cosmetic powders. However, the daily intake of cadmium by the newborns was lower than tolerable daily intake of the WHO for 97% of them. Our results revealed low cadmium concentrations in human milk samples from Moroccan lactating mothers living in Rabat, also the association of some factors with the levels of contamination found in this population.


  • Total, organic, and inorganic mercury in human breast milk: levels and maternal factors of exposure, systematic literature review, 1976–2017

    by Abha Cherkani-Hassani, Imane Ghanname, Nezha Mouane

    This systematic review summarizes the finding of 58 studies from 33 countries, which assessed mercury concentrations in breast milk and the factors related to the level of contamination. We performed a literature search in Pubmed, Science Direct, and Google Scholar databases for studies published between 1976 and 2017 that are monitoring and measuring mercury in human breast milk and investigating the associated factors. Then, we extracted more information about the aim of the study, the country, samples size, time of lactation, mercury concentration, and other data. Most of the studies used mature milk or colostrum for analysis and in about 60% of them, the concentrations exceed significantly the limit set by the World Health Organization (WHO) of 1.7 µg/l; In addition, many factors and parameters were related to the level of mercury contamination in breast milk. Periodic monitoring surveys are recommended in each country to evaluate the level of mercury in milk of lactating women and to estimate the level of exposure of newborns.